Calsequestrin 2 deletion shortens the refractoriness of Ca 2+ release and reduces rate-dependent Ca 2+-alternans in intact mouse hearts

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 1, 2012, Pages 21-31

  Kornyeyev, Dmytro ^a   Petrosky, Azade D ^a   Zepeda, Bernardo ^a   Ferreiro, Marcela ^a   Knollmann, Bjorn ^b   Escobar, Ariel L ^a  

^a Merced   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Alternans; Calcium; Calsequestrin; Ventricular arrhythmias; Whole heart

Indexed keywords

CALCIUM; CALSEQUESTRIN; CALSEQUESTRIN 2; UNCLASSIFIED DRUG;

ARTICLE; BRADYCARDIA; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOSOL; ELECTROCARDIOGRAM; EPICARDIUM; EXTRACELLULAR CALCIUM; GENE DELETION; HEART; HEART BEAT; HEART RATE; HEART VENTRICLE; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM; T WAVE; T WAVE ALTERNANS; TRANSPORT KINETICS;

ANIMALS; CALCIUM; CALCIUM SIGNALING; CALSEQUESTRIN; CYTOSOL; GENE KNOCKOUT TECHNIQUES; MICE; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; MYOCARDIUM; PERICARDIUM; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; SARCOPLASMIC RETICULUM;

MUS;

EID: 84155180945     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.09.020     Document Type: Article

References (39)

1. Campbell K.P., MacLennan D.H., Jorgensen A.O., Mintzer M.C. Purification and characterization of calsequestrin from canine cardiac sarcoplasmic reticulum and identification of the 53,000 dalton glycoprotein. J Biol Chem 1983, 258:1197-1204.
2. Flucher B.E., Franzini-Armstrong C. Formation of junctions involved in excitation-contraction coupling in skeletal and cardiac muscle. Proc Natl Acad Sci USA 1996, 93:8101-8106.
3. Endo M., Tanaka M., Ogawa Y. Calcium induced release of calcium from the sarcoplasmic reticulum of skinned skeletal muscle fibers. Nature 1970, 228:34-36.
4. Fabiato A., Fabiato F. Contractions induced by a calcium-triggered release of calcium from the sarcoplasmic reticulum of single skinned cardiac cells. J Physiol 1975, 49:469-495.
5. 2+ binding effects on protein conformation and protein interactions of canine cardiac calsequestrin. J Biol Chem 1988, 263:1376-1381.
6. Györke S., Terentyev D. Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease. Cardiovasc Res 2008, 77:245-255.
7. Sato Y., Ferguson D.G., Sako H., Dorn G.W., Kadambi V.J., Yatani A., et al. Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J Biol Chem 1998, 273:28470-28477.
8. Knollmann B.C., Knollmann-Ritschel B.E., Weissman N.J., Jones L.R., Morad M. Remodeling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin. J Physiol (Lond) 2000, 525:483-498.
9. Györke I., Hester N., Jones L.R., Györke S. The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to lumenal calcium. Biophys J 2004, 86:2121-2128.
10. Terentyev D., Viatchenko-Karpinski S., Vedamoorthyrao S., Oduru S., Györke I., Williams S.C., et al. Protein-protein interactions between triadin and calsequestrin are involved in modulation of sarcoplasmic reticulum calcium release in cardiac myocytes. J Physiol 2007, 583:71-80.
11. Lahat H., Pras E., Olender T., Avidan N., Ben-Asher E., Man O., et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet 2001, 69:1378-1384.
12. Postma A.V., Denjoy I., Hoorntje T.M., Lupoglazoff J.-M., Da Costa A., Sebillon P., et al. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ Res 2002, 91:e21-e26.
13. Liu N., Priori S.G. Disruption of calcium homeostasis and arrhythmogenesis induced by mutations in the cardiac ryanodine receptor and calsequestrin. Cardiovasc Res 2008, 77:293-301.
14. 2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 2006, 116:2510-2520.
15. 2+ and trigger ventricular arrhythmias in mice. Circ Res 2007, 101:617-626.
16. 2+ in cardiomyocytes. J Physiol 2009, 587:5003-5004.
17. Alcalai R., Wakimoto H., Arad M., Planer D., Konno T., Wang L., et al. Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation. J Cardiovasc Electrophysiol 2011, 22:316-324.
18. 2+ reserve. Circ Res 2003, 93:40-45.
19. 2+ release in subepicardial myocytes of intact beating mouse hearts: effect of exogenous buffers. Am J Physiol Heart Circ Physiol 2010, 298:H2138-H2153.
20. Dou Y., Arlock P., Arner A. Blebbistatin specifically inhibits actin-myosin interaction in mouse cardiac muscle. Am J Cell Physiol 2007, 293:1148-1153.
21. Fedorov V.V., Lozinsky I.T., Sosunov E.A., Anyukhovsky E.P., Rosen M.R., Balke C.W., et al. Application of blebbistatin as an excitation-contraction uncoupler for electrophysiologic study of rat and rabbit hearts. Heart Rhythm 2007, 4:619-626.
22. Farman G., Tachampa K., Mateja R., Carzorla O., Lacampagne A., de Tombe P.P. Blebbistatin: use as inhibitor of muscle contraction. Pflugers Arch - Eur J Physiol 2008, 455:995-1005.
23. 2+ depletion of the sarcoplasmic reticulum at the onset of reperfusion. Cardiovasc Res 2010, 85:671-680.
24. Mejía-Alvarez R., Manno C., Villalba-Galea C.A., del Valle Fernández L., Costa R., Fill M., et al. Pulsed local-field fluorescence microscopy: a new approach for measuring cellular signals in the beating heart. Pflugers Arch 2003, 445:747-758.
25. Diaz M.E., Trafford A.W., Eisner D.A. The effect of exogenous calcium buffers on the systolic calcium transient in rat ventricular myocytes. Biophys J 2001, 20:1915-1925.
26. Pham Q., Quan K.J., Rosenbaum D.S. T-wave alternans: marker, mechanism, and methodology for predicting sudden cardiac death. J Electrocardiol 2003, 36:75-81.
27. 2+ release contributes to automaticity in cat atrial pacemaker cells. J Physiol 2000, 524:415-422.
28. 2+ waves in cat atrial myocytes. J Physiol 2002, 545:65-79.
29. Blatter L.A., Kockskamper J., Sheehan K.A., Zima A.V., Huser J., Lipsius S.L. Local calcium gradients during excitation-contraction coupling and alternans in atrial myocytes. J Physiol 2003, 546:19-31.
30. Terentyev D., Viatchenko-Karpinski S., Györke I., Volpe P., Williams S.C., Györke S. Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: mechanism for hereditary arrhythmia. Proc Natl Acad Sci USA 2003, 100:11759-11764.
31. Viatchenko-Karpinski S., Terentyev D., Györke I., Terentyeva R., Volpe P., Priori S.G., et al. Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin. Circ Res 2004, 94:471-477.
32. 2+ release in cardiac myocytes. Circ Res 2002, 91:414-420.
33. Del Principe F., Egger M., Niggli E. Calcium signalling in cardiac muscle: refractoriness revealed by coherent activation. Nat Cell Biol 1999, 1:323-329.
34. 2+ release refractoriness in heart muscle. Circ Res 2004, 95:807-813.
35. 2+ blinks: rapid nanoscopic store calcium signaling. Proc Natl Acad Sci USA 2005, 102:3099-3104.
36. i waves in cardiac myocytes. Am J Physiol 1996, 270:C148-C159.
37. 2+ release in rat ventricular myocytes. J Physiol 2005, 565:441-447.
38. Terentyev D., Kubalova Z., Valle G., Nori A., Vedamoorthyaro S., Terentyeva R., et al. Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes: effects of CASQ2 mutations linked to sudden cardiac death. Biophys J 2008, 95:2037-2048.
39. Györke S. Molecular basis of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2009, 6:123-129.